2022 ICD-10-CM Code D07

Carcinoma in situ of other and unspecified genital organs

Version 2021

Not Valid for Submission

ICD-10:D07
Short Description:Carcinoma in situ of other and unspecified genital organs
Long Description:Carcinoma in situ of other and unspecified genital organs

Code Classification

  • Neoplasms (C00–D48)
    • In situ neoplasms (D00-D09)
      • Carcinoma in situ of other and unspecified genital organs (D07)

D07 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of carcinoma in situ of other and unspecified genital organs. The code is not specific and is NOT valid for the year 2022 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

Unspecified diagnosis codes like D07 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.

Specific Coding for Carcinoma in situ of other and unspecified genital organs

Non-specific codes like D07 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for carcinoma in situ of other and unspecified genital organs:

  • BILLABLE CODE - Use D07.0 for Carcinoma in situ of endometrium
  • BILLABLE CODE - Use D07.1 for Carcinoma in situ of vulva
  • BILLABLE CODE - Use D07.2 for Carcinoma in situ of vagina
  • NON-BILLABLE CODE - D07.3 for Carcinoma in situ of other and unspecified female genital organs
  • BILLABLE CODE - Use D07.30 for Carcinoma in situ of unspecified female genital organs
  • BILLABLE CODE - Use D07.39 for Carcinoma in situ of other female genital organs
  • BILLABLE CODE - Use D07.4 for Carcinoma in situ of penis
  • BILLABLE CODE - Use D07.5 for Carcinoma in situ of prostate
  • NON-BILLABLE CODE - D07.6 for Carcinoma in situ of other and unspecified male genital organs
  • BILLABLE CODE - Use D07.60 for Carcinoma in situ of unspecified male genital organs
  • BILLABLE CODE - Use D07.61 for Carcinoma in situ of scrotum
  • BILLABLE CODE - Use D07.69 for Carcinoma in situ of other male genital organs

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D07:


Type 1 Excludes

Type 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

Information for Patients


Cancer

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Most treatment plans may include surgery, radiation and/or chemotherapy. Some may involve hormone therapy, immunotherapy or other types of biologic therapy, or stem cell transplantation.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)